The Tennessee Department of Commerce & Insurance (TDCI) and the Tennessee Motor Vehicle Commission are alerting auto buyers ...
Officials are alerting auto buyers to the increased presence of illegal and unlawful advertisements being sent from licensed ...
Mobile advertising is advertising designed to appear on mobile devices such as smartphones and tablets. It is optimized for ...
The latest lawsuit against Meta was filed in Washington, D.C. by the Consumer Federation of America, a nonprofit association of more than 200 organizations that represent consumer interest. The ...
A lawsuit from the Consumer Federation of America accuses Meta of misleading consumers about its efforts to combat scams advertisements on its platforms. On Tuesday, the nonprofit Consumer Federation ...
INDIANAPOLIS (WISH) — The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight loss drugs, ...
Multiple district attorney's offices in Northern California resolved a misleading advertising case with a company that wrongly marketed its materials as plastic-free, the Monterey County District ...
State Treasurer Robert Sprague is running campaign ads in his bid to become the next Ohio Secretary of State. While the ads are colorful and amusing, Sprague forgot to mention one important fact: ...
NEW YORK, April 16, 2026 /PRNewswire/ -- Institutional investors holding positions in ODDITY Tech Ltd. (NASDAQ: ODD) during the period February 26, 2025 through February 24, 2026 may wish to evaluate ...
The US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, issuing three new untitled letters ...
The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately communicate the indication, contraindications and risks. Continuing a wave ...
Regulators claim Pfizer’s ads created a misleading impression by describing Adcetris as a treatment for broader T-cell lymphoma populations than those covered by its FDA-approved label. The FDA also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results